Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Gastrointestinal strictures impact clinical presentation in abdominal tuberculosis and are associated with significant morbidity.
Aim: To conduct a systematic review of the prevalence of stricturing disease in abdominal and gastrointestinal tuberculosis and response to antitubercular therapy (ATT).
Methods: We searched Pubmed and Embase on 13th January 2022, for papers reporting on the frequency and outcomes of stricturing gastrointestinal tuberculosis. The data were extracted, and pooled prevalence of stricturing disease was estimated in abdominal tuberculosis and gastrointestinal (intestinal) tuberculosis. The pooled clinical response and stricture resolution (endoscopic or radiologic) rates were also estimated. Publication bias was assessed using the Funnel plot and Egger test. The risk of bias assessment was done using a modified Newcastle Ottawa Scale.
Results: Thirty-three studies reporting about 1969 patients were included. The pooled prevalence of intestinal strictures in abdominal tuberculosis and gastrointestinal TB was 0.12 (95%CI 0.07-0.20, I = 89%) and 0.27 (95% CI 0.21-0.33, I = 85%), respectively. The pooled clinical response of stricturing gastrointestinal tuberculosis to antitubercular therapy was 0.77 (95%CI 0.65-0.86, I = 74%). The pooled stricture response rate (endoscopic or radiological) was 0.66 (95%CI 0.40-0.85, I = 91%). The pooled rate of need for surgical intervention was 0.21 (95%CI 0.13-0.32, I = 70%), while endoscopic dilatation was 0.14 (95%CI 0.09-0.21, I = 0%).
Conclusion: Stricturing gastrointestinal tuberculosis occurs in around a quarter of patients with gastrointestinal tuberculosis, and around two-thirds of patients have a clinical response with antitubercular therapy. A subset of patients may need endoscopic or surgical intervention. The estimates for the pooled prevalence of stricturing disease and response to ATT had significant heterogeneity.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948355 | PMC |
| http://dx.doi.org/10.1186/s12876-023-02682-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mannosylated chitosan-decorated PLGA nanoparticles for targeted pulmonary delivery of isoniazid: a promising approach in the treatment of tuberculosis.
J Drug Target
September 2025
School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, P. R. China.
Tuberculosis (TB), caused by (M. tb), represents a significant challenge to global health. The management of the disease requires an extended course of antibiotic therapy, spanning a duration of 6 to 9 months.
View Article and Find Full Text PDFBoron nitride quantum dot-based fluorescent sensor for carbamazepine determination in exhaled breath condensate.
Anal Biochem
August 2025
Pharmaceutical Analysis Research Center, Pharmaceutical Sciences Institute, Tabriz University of Medical Sciences, Tabriz, Iran; Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Carbamazepine is a widely prescribed antiepileptic drug with a narrow therapeutic index, necessitating precise monitoring to avoid toxicity and ensure therapeutic efficacy. This study presents a fluorescence-based nanosensor using boron nitride quantum dots (BNQDs) for the rapid and sensitive detection of carbamazepine in exhaled breath condensate (EBC). BNQDs were prepared via a simple hydrothermal technique and characterized using transmission electron microscopy, dynamic light scattering, energy-dispersive X-ray, and attenuated total reflectance-Fourier transform infrared techniques.
View Article and Find Full Text PDFRespiratory diseases and the gut microbiota: an updated review.
Front Cell Infect Microbiol
August 2025
Department of Pathogen Biology, College of Basic Medical Sciences, Jilin University, Changchun, China.
The gut microbiota constitutes a vital ecosystem within the human body playing a pivotal role in immune regulation and metabolic homeostasis. Emerging research underscores a sophisticated interplay between the gut and lungs, termed the "gut-lung axis." Gut microbes exert influence over pulmonary immunity and metabolism via immune mediators (e.
View Article and Find Full Text PDFRectal tuberculosis in a 48-years-old immuno-competent man: A rare case report.
Int J Surg Case Rep
August 2025
Kathmandu University School of Medical Sciences, Dhulikhel, Nepal.
Introduction: Rectal tuberculosis (TB) is one of the rare presentations of gastrointestinal tuberculosis that often mimics malignancy or inflammatory bowel disease (IBD), presenting as fistulas, ulcers, and chronic pain. Rectal TB is very rare in immunocompetent patients. The mainstay of diagnosis is colonoscopy-guided biopsy.
View Article and Find Full Text PDFAppendiceal malakoplakia: a review of the literature and case presentation.
Rom J Morphol Embryol
August 2025
Department of Surgery, University of Medicine and Pharmacy of Craiova, Romania;
Background∕Objectives: Malakoplakia is an uncommon clinicopathological entity defined by the accumulation of dysfunctional macrophages containing undigested bacterial remnants and pathognomonic Michaelis-Gutmann bodies. Although it most frequently involves the gastrointestinal tract, particularly the colon, rectum, and rectosigmoid junction, appendiceal involvement remains rare. This case represents only the fourth reported occurrence of appendiceal malakoplakia in a young, immunocompetent adult without notable comorbidities, underscoring its exceptional clinical presentation.
View Article and Find Full Text PDF